AIDS Research and Treatment / 2015 / Article / Tab 2

Research Article

Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN Trial

Table 2

Efficacy results at week 48 for protease inhibitor naïve patients in the ODIN trial.

Darunavir/ritonavir
800/100 mg once daily
Darunavir/ritonavir
600/100 mg twice daily

135137
HIV-1 RNA <50 copies/mL111 (82%)109 (80%)
HIV-1 RNA <400 copies/mL118 (87%)115 (84%)

All results shown are (%), unless otherwise stated.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.